Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. 2008

Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
Mattel Children's Hospital, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. mstuber@mednet.ulca.edu

Non-adherence with recommended immunosuppressant medications is common post-pediatric liver transplant and is the most important reason for organ rejection in long-term survivors. However, there is currently no validated, standard method to measure adherence, with a well-defined threshold, making it extremely difficult to evaluate interventions to improve adherence. Previous studies have suggested that the degree of fluctuation of medication blood levels over time can provide an idea about how regularly the medication is being taken. The present study, conducted at UCLA medical center, sought to identify a specific threshold value of the s.d. of individual tacrolimus blood levels in pediatric liver transplant recipients which would be associated with rejection episodes in these patients. A threshold of 3.0 has been identified in other studies, and was supported by the analysis of retrospective data from 96 subjects. However, further analysis found that a s.d. of 2.5 appeared to have a better fit with the data. These findings suggest the utility of monitoring the s.d. of routine tacrolimus blood levels in pediatric liver transplant recipients for detecting non-adherence to immunosuppressant medication prior to clinical rejection, allowing earlier interventions.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D010372 Pediatrics A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections

Related Publications

Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
May 2008, Pediatric transplantation,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
May 2024, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
November 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
March 2005, Transplantation proceedings,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
May 2021, Pediatric transplantation,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
June 2023, Journal of clinical medicine,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
December 2004, Pediatric transplantation,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
January 2012, Clinical transplantation,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
January 2012, Research in social & administrative pharmacy : RSAP,
Margaret L Stuber, and Eyal Shemesh, and Debra Seacord, and James Washington, and Gerhard Hellemann, and Susan McDiarmid
October 2018, International journal of clinical pharmacy,
Copied contents to your clipboard!